## **Core Concept**
Hereditary hemorrhagic telangiectasia (HHT) is a genetic disorder characterized by the formation of abnormal blood vessels, leading to complications such as nosebleeds, gastrointestinal bleeding, and vascular malformations. The disorder is primarily associated with mutations in two genes: **ENG** (endoglin) and **ALK1** (activin receptor-like kinase 1), which are involved in the TGF-β (transforming growth factor-beta) signaling pathway.

## **Why the Correct Answer is Right**
The correct answer, **.**, corresponds to HHT type 2, which is commonly associated with mutations in the **ALK1** gene. The **ALK1** gene provides instructions for making a protein called activin receptor-like kinase 1, which is involved in the TGF-β signaling pathway. This pathway plays a critical role in the development and maintenance of blood vessels. Mutations in **ALK1** lead to the formation of abnormal blood vessels characteristic of HHT.

## **Why Each Wrong Option is Incorrect**
- **Option A:** HHT type 1 is primarily associated with mutations in the **ENG** gene, not **ALK1**.
- **Option B:** This option does not correspond to a commonly recognized classification of HHT related to **ALK1** mutations.
- **Option D:** This option is not specifically linked to **ALK1** mutations in the context of HHT.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that patients with HHT are at risk for developing arteriovenous malformations (AVMs), particularly in the lungs, liver, and brain. Early diagnosis and treatment of AVMs can significantly reduce the risk of complications and mortality in these patients. The association of **ALK1** mutations with HHT type 2 and the resultant clinical manifestations is crucial for genetic counseling and management.

## **Correct Answer:** . HHT Type 2